16758259Kim MJ, Nafziger AN, Kashuba AD, Kirchheiner J, Bauer S, Gaedigk A, Bertino JSEuropean journal of clinical pharmacologyAryl Hydrocarbon Hydroxylases; Fatty Acids, Monounsaturated; Indoles; SmokingAdult; Cross-Over Studies; Cytochrome P-450 CYP2C9; Enzyme Inhibitors; Female; Fluvastatin; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Stereoisomerism; WarfarinKim MJ, Nafziger AN, Kashuba AD, Kirchheiner J, Bauer S, Gaedigk A, Bertino JS. Effects of fluvastatin and cigarette smoking on CYP2C9 activity measured using the probe S-warfarin. Eur J Clin Pharmacol. 2006 Jun; 62(6):431-6.Eur J Clin Pharmacol2006-04-27T00:00:002006Effects of fluvastatin and cigarette smoking on CYP2C9 activity measured using the probe S-warfarin.cmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD008297Physiology11633280.54802MaleD008875Concepts & IdeasLiving Beings836510.853398Middle AgedD010597Occupations141720.851158PharmacogeneticsAuthorship 25360.07223780.07223781authors10.2516has subject areaD012907Activities & Behaviors14710.936299SmokingD013237Chemicals & DrugsConcepts & IdeasPhenomena490.997946StereoisomerismD014859Chemicals & Drugs3120.994453WarfarinD018592Procedures20320.990306Cross-Over Studies1ProfessorD065729Chemicals & Drugs7250.983596Cytochrome P-450 CYP2C9PediatricsResearchPhD, MSAndreaGaedigkAndrea Gaedigk39.08346750000000-94.577112900000001Gaedigk, Andrea0000-0001-6968-1893Director, Pharmacogenetics Core LaboratoryD000328Living Beings11012590.736773AdultChildren's Mercy Kansas CityD001189Chemicals & Drugs5410.973439Aryl Hydrocarbon Hydroxylasestrue1Director, Pharmacogenetics Core LaboratoryDirector, Pharmacogenetics Core LaboratoryD004791Chemicals & Drugs10190.995099Enzyme InhibitorsD005229Chemicals & Drugs110.999639Fatty Acids, MonounsaturatedD005260Physiology11835990.534568FemaleD005838Physiology404010.883905GenotypeD006801Living Beings12067970.397999HumansD007211Chemicals & Drugs330.997899Indoles